文献速递心脑血管急症重症综合管理与镇静镇痛

蛛网膜下腔出血患者的长期临床轨迹:连接急性期监护与神经康复

Long-Term Clinical Trajectory of Patients with Subarachnoid Hemorrhage: Linking Acute Care and Neurorehabilitation.
PubMed 文献 · Neurocrit Care · 2022-08-12
一句话结论前瞻性队列显示,蛛网膜下腔出血存活者1年内73%功能改善,即使转至神经康复中心时重度残疾,仍有60%在住院康复期间改善。

该前瞻性研究连续纳入298例自发性蛛网膜下腔出血患者,在出院时、3个月和1年评估临床轨迹,并分析转至当地神经康复中心(Rehab-Hochzirl)亚组中康复强度的影响。250例存活者中,57%(122/215)在最初3个月功能改善,另有16%(35/215)在3至12个月改善,总体73%(157/215)存活者改善;1年后60%(179/250)功能独立。ICU入院时较低的Hunt和Hess评分、较年轻年龄、ICU出院时较低的mRS、较少的机械通气天数及男性与更好的功能恢复独立相关。转至Rehab-Hochzirl的亚组病情更重,但60%(52/87)在住院神经康复期间改善。

要点

  • 298例自发性SAH前瞻性随访1年,250例存活者中73%(157/215)功能改善,60%(179/250)在1年时功能独立(mRS≤2)。
  • 功能改善主要发生在最初3个月(57%,122/215),3至12个月仍有16%(35/215)额外改善。
  • 转至Rehab-Hochzirl的87例出院时mRS=4,病情更重,但60%(52/87)在住院神经康复期间改善。
  • ICU入院时较低Hunt和Hess评分、较年轻年龄、ICU出院时较低mRS、较少机械通气天数及男性与更好功能恢复独立相关。

适用人群与场景

  • 连续纳入的298例自发性蛛网膜下腔出血患者,前瞻性随访至出院、3个月和1年。
  • 存活者250例,转归包括直接转至Rehab-Hochzirl(87/250,出院时mRS=4)、转至其他康复中心(27/250,mRS=1)、转至养老院(3/250,mRS=5)、转回原籍国(52/250,mRS=4)及出院回家(79/250,mRS=1)。
  • 亚组分析:转至当地神经康复中心Rehab-Hochzirl的患者。

诊断标准与关键阈值

  • 功能改善定义为改良Rankin量表(mRS)任何下降;良好结局定义为mRS≤2。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,连续纳入298例自发性SAH患者,评估出院、3个月和1年临床轨迹;对转至Rehab-Hochzirl的亚组分析康复强度的影响。
  • 250例存活者中,35%(87/250;出院时mRS=4)直接转至Rehab-Hochzirl,11%(27/250;mRS=1)转至其他康复中心,1%(3/250;mRS=5)转至养老院,21%(52/250;mRS=4)转回原籍国,32%(79/250;mRS=1)出院回家。
  • 功能结局在最初3个月改善57%(122/215),3至12个月额外改善16%(35/215),总体改善73%(157/215)。
  • 1年后60%(179/250)患者功能独立。
  • 多因素分析:ICU入院时较低的Hunt和Hess评分、较年轻年龄、ICU出院时较低的mRS、较少的机械通气天数及男性与更好的功能恢复独立相关。
  • 转至Rehab-Hochzirl的亚组病情更重,但60%(52/87)在住院神经康复期间改善。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,SAH后12个月随访期内相当比例患者持续功能改善,此效应在接受住院神经康复的重度残疾患者中亦可见。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Despite improvements in the critical care management of subarachnoid hemorrhage (SAH), a substantial number of patients still suffer from disabilities. In most areas of the world, longitudinal follow-up is not routinely performed, and the patient's trajectory remains unknown.

METHODS: We prospectively collected data of 298 consecutive patients with spontaneous SAH and evaluated clinical trajectories at discharge, 3 months, and 1 year after SAH. In a subgroup of patients transferred to a local neurorehabilitation center (Rehab-Hochzirl), we studied the effects of rehabilitation intensity on clinical trajectories. Any decrease in the modified Rankin Scale (mRS) was defined as an improvement, with mRS ≤ 2 indicating good outcome. We used multivariate generalized linear models to investigate associations with clinical trajectories.

RESULTS: Out of the 250 surviving patients, 35% were transferred directly to Rehab-Hochzirl (n = 87 of 250; mRS at discharge = 4), 11% were transferred to another rehabilitation center (n = 27 of 250; mRS = 1), 1% were transferred to a nursing home (n = 3 of 250; mRS = 5), 21% were transferred to their country of origin (n = 52 of 250; mRS = 4), and 32% (n = 79 of 250; mRS = 1) were discharged home. Functional outcome improved in 57% (n = 122 of 215) of patients during the first 3 months, with an additional 16% (35 of 215) improving between 3 and 12 months, resulting in an overall improvement in 73% (n = 157 of 215) of survivors. After 1 year, 60% (n = 179 of 250) of patients were functionally independent. A lower Hunt and Hess scale score at intensive care unit admission, younger age, a lower mRS at intensive care unit discharge, fewer days on mechanical ventilation, and male sex were independently associated with better functional recovery. Although the subgroup of patients transferred to Rehab-Hochzirl were more severely affected, 60% (52 of 87) improved during inpatient neurorehabilitation.

CONCLUSIONS: Our results indicate ongoing functional improvement in a substantial number of patients with SAH throughout a follow-up period of 12 months. This effect was also observed in patients with severe disability receiving inpatient neurorehabilitation.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Lindner A, Brunelli L, Rass V, et al. Long-Term Clinical Trajectory of Patients with Subarachnoid Hemorrhage: Linking Acute Care and Neurorehabilitation. Neurocrit Care. 2022. PMID: 35962231. doi:10.1007/s12028-022-01572-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。